Skip to content
Saturday 29 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,824.26
+0.29%
DAX
26,569.99
+0.77%
CAC 40
8,401.18
+0.98%
STOXX 50
6,485.67
+0.95%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE

Businesswire

  • IFF Announces Agreement to Sell Its Portfolio of Botanical Extracts, Vitamins & Minerals and Food Enhancement Activities to SuanNutra, a Portfolio Company of Carbyne Equity Partners.

    July 20, 2026

    IFF (NYSE: IFF) — a global leader in flavors, fragrances, and health and biosciences — today announced that it has entered into an agreement with SuanNutra, a Carbyne Equity Partners portfolio company and global provider of science-backed branded and functional ingredients, to sell its portfolio of botanical extracts, vitamins and minerals, and food enhancement activities, [...]

  • New CultureLab Findings Show Culturally Relevant Brands Worth Nearly Three Times More

    July 20, 2026

    As CMOs get less for every media dollar they spend and as brand investment in creators grows, new research reveals what the world's most valuable brands are doing differently

  • Almirall Announces EMA Acceptance for Filing of Paediatric Registration of Ebglyss (Lebrikizumab) in Atopic Dermatitis in Children 6 Months and Older

    July 20, 2026

    The EMA application is supported by data from the paediatric clinical programme for lebrikizumab, including the pivotal Phase III ADorable-1 study and the ADorable-2 long-term extension study. Atopic dermatitis affects a significant number of children and adolescents and often peaks in childhood – with around 60% of cases appearing within the first year of life1. As atopic dermatitis often begins early in life and can have a lasting impact on patients and their families, effective disease control is increasingly recognised as an important opportunity to reduce long-term disease burden and support healthier life trajectories2.

  • Agilent Increases Its Investment in HALO X-ray Technologies

    July 20, 2026

    Validation of HALO’s Advanced Security Screening Technology Agilent Technologies, Inc. has led a multimillion dollar investment round in which other existing Blue Chip investors UK Innovation Science Seed Fund (UKI2S) and the Midland Engine Investment Fund (MEIF) also participated. The investment enables HALO to complete regulatory approval of its advanced security screening technology ahead of production and scaling up its commercial activities.

  • Eaton Opens European Aerospace Additive Manufacturing Center to Expand Production and Strengthen Regional Supply Chain Resilience

    July 20, 2026

    Specialized center delivers production-ready capabilities closer to European aerospace commercial, aftermarket and defense customers Eaton chooses U.K. for its third global additive manufacturing site and second dedicated to the aerospace industry

  • KBRA Releases UK RMBS Indices: Q2 2026

    July 17, 2026

    KBRA releases its UK RMBS Indices: Q2 2026. The indices track early-, mid-, and late-stage delinquencies, annualised net losses, and prepayment activity across prime, buy-to-let (BTL), and nonconforming (NC) mortgage collateral. Click here to view the report. About KBRA KBRA, one of the major credit rating agencies, is registered in the U.S., EU, and the [...]

  • Dilosk Agrees Sale to Pepper Advantage

    July 17, 2026

    Dilosk DAC, trading as Dilosk and ICS Mortgages (“Dilosk”), a leading Irish residential mortgage origination and servicing platform, today announces that it has entered into an agreement for the sale of the business to Pepper Advantage, which is wholly owned by J.C. Flowers & Co., a global private investment firm specialising in financial services. Following [...]

  • Modon Holding and Nammos Hotels & Resorts Bring Nammos Ras El Hekma to Egypt’s North Coast

    July 16, 2026

    Developed in partnership with Nammos Hotels & Resorts, the landmark Mediterranean destination will bring together branded residences, a luxury resort, restaurant and beach club, retail village, and signature dining and wellness experiences to Egypt for the first time.

  • Elliptic Launches Next-Generation Continuous Monitoring, Giving Crypto Compliance Teams a Live View of Customer Risk Without the Flood of Alerts

    July 16, 2026

    The only monitoring solution on the market that detects the full range of risk-changing events, not just label changes, and lets teams configure alerts to only what matters, cutting manual rescreening and alert triage by up to 75%

  • MultiBank Group Named Forex Broker of the Year 2026 at Money Expo Abu Dhabi

    July 16, 2026

    MultiBank Group, one of the world’s largest and most regulated online financial derivatives institutions, has been named Forex Broker of the Year at Money Expo Abu Dhabi. The event was held on 8–9 July 2026 at the ADNEC Centre. This flagship award recognizes the broker setting the benchmark for excellence across the global trading and [...]

Posts pagination

  • Previous
  • Page 1
  • …
  • Page 28
  • Page 29
  • Page 30
  • Page 31
  • Page 32
  • …
  • Page 229
  • Next

Trending Articles

  • Pensioners to hand over bank statements in government benefits crackdown

  • Jamie Carragher: HMRC petitions for Sky Sports star to be declared bankrupt

  • Brewdog founder James Watt hits out at ‘total silence’ over new venture

  • Jamie Vardy bags Bundesliga rights as he steps up streaming war with Neville and Lineker

  • Lloyds Bank and Halifax users unable to use app in latest outage

MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook